Assignee
LANOVA MEDICINES DEV CO LTD
CN·3 granted patents·4 pending applications·1 citations·filing 2022–2025
Top patents by PatentIndex Score
7 records- 0186US11485783B2Anti-GPRC5D monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2022·Granted Nov 1, 2022·1 cites·24 claims
- 0275US12281162B2Chimeric antigen receptors targeting GPRC5DLANOVA MEDICINES DEV CO LTD·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 0374US12215150B2Anti-SLC34A2 monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2024·Granted Feb 4, 2025·0 cites·17 claims
- 0470US2025388671A1Chimeric antigen receptors targeting gprc5dLANOVA MEDICINES DEV CO LTD·Filed 2025·Application pending·0 cites
- 0560US2025163164A1Anti-il-13ra2 monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2023·Application pending·0 cites
- 0659US2024400701A1Anti-amhrii antibodiesLANOVA MEDICINES DEV CO LTD·Filed 2022·Application pending·0 cites
- 0756US2025154248A1Anti-slc34a2 monoclonal antibodies and uses thereofLANOVA MEDICINES DEV CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LANOVA MEDICINES DEV CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →